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A case vignette:  
"43 years old zamindar from Punjab, Pakistan,
presented in a psychiatry clinic with increasing restlessness,
palpitation, shortness of breath, insomnia since 3 days.
Symptoms became pronounced after stopping all
medications, prior to consultation. Upon seeing the
psychiatrist, he insisted on intravenous (I/V) injection of
Valium. When informed about the hazardous effects of
prolonged benzodiazepine use, Mr NB was quick to point
out that previous physicians were quite liberal in the use of
requested medication. In fact his last physician has
prescribed Tab. Alprazolam (2 mg) three times a day,
besides intravenous, Valium 10 mg,  once or twice a week. 
NB started using Tab. Alprazolam (0.5 mg), once in
a while, four years ago, on advice of a 'friend', who was a
Doctor. This was due to a psychosocial stressor; many years
after the marriage couple had no issues. Work-up revealed
that he has 'Azospermia'. This stressor was subsequently
buried under the pile of investigations by general
physicians, internists and gastroenterologists. He carried a
'thick folder' containing reports of endoscopies,
echocardiograms, ECG's besides repeated Biochemistry
investigations. He was prescribed various compounds from
the benzodiazepine group, always with the reassurance that
nothing is 'wrong' with him. 
He was diagnosed to have Somatoform disorder —
undifferentiated type and benzodiazepine dependence
syndrome. Subsequently he was advised admission for
Detoxification and Management of this iatrogenic
complication."
Background
In the context of Pakistan, a developing South Asian
country, cases like these are norm rather then an exception.
Physicians prescribe these medications indiscriminately,
without supervision. To add to the problem, in the absence
of robust legislation and its lack of implementation,
benzodiazepines are available over the counter; they can be
acquired without any one asking any questions.
Alprazolam, is one of the benzodiazepine which is
registered and available over the counter by around 20
trade names. Unlike Pakistan, Benzodiazepines are enlisted
as controlled drugs (CDs) in the United Kingdom (UK) and
therefore supply is regulated by the Misuse of Drugs
Act.1971. Although, legislation surrounding the supply and
management of CDs was fairly stringent before the
Shipman incident, post-Shipman inquiry has tightened the
legislation even more.1
This problem has multiple facets; health care system
related factors, legislation and economic factors contribute
to the overall burden of problem. Some of these would be
highlighted in this review. 
In Pakistan, there is a dearth of properly trained and
qualified psychiatrists (in all, 320). The psychiatrist to
population ratio is dismally low. In a recent World Health
Organization (WHO) facts sheet it was estimated to be
0.2/100,000. Most of these professionals are centered in
urban areas. Almost 67 % population resides in rural areas
to which mental health care is delivered by general
physicians. Prevalence estimates of common mental
disorders is about 30% - ranging from 10-to-25% in urban
settings to 30-to-66% in rural settings.2
Tranquilizers have become an accepted component
in the lives of a large segment of our population. By a
conservative estimate around seven to ten million urban
dwellers in Pakistan continue to consume these medications
regularly. Most of these medication are available over-the-
counter without any medical prescription.3
Benzodiazepines misuse: 
The most commonly used tranquilizers are
Pharmacological compounds called Benzodiazepines. Not
only in Pakistan but around the world benzodiazepines are
among the most prescribed and consumed medication
groups. The discovery of first Benzodiazepine,
Chlordiacepoxide, in 1957 by Leo Stern Bach was a
landmark in modern psychopharmacology.4
Chlordiacepoxide was soon followed by a large number of
similar compounds, which were quickly introduced in
clinical practice, becoming among the most successful
drugs ever introduced. 
Various compounds from the group of
Benzodiazepine are available in the market. They are
marketed with various attractive names and labels; it is not
uncommon to see adjectives like tranquility, serenity and
relaxation intertwined in the names of some compounds.
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These seductive labels are heinous efforts to sell the drugs.
The existence of Benzodiazepine dependence was described
in the early sixties with very high dose of chlordiazepoxide
but it has become a real concern for the medical community
since the late seventies with increasing number of reports of
withdrawal symptoms. 
If this is not enough, benzodiazepines are the most
favored medication of self-harm. In the context of Pakistan,
this has stemmed from their status as sleeping pills; in an
overdose one would expect a person to 'sleep forever'.
Favorably there pharmacological lethality index is very
high. However this in no way makes them any less
dangerous than other drugs of overdose. 
What does local research tells us: 
If we look at the research carried out in developed
countries, Benzodiazepine overdose is the most common
way of self-poisoning among the substance induced suicidal
attempts, accounting for about 40% of the total.  A study
done in Germany reports this proportion to be 32%. The
study also reveals that 80% of the drugs used in self-
poisoning were prescribed by physicians' themselves.5
In a study done in Pakistan the proportion of
Benzodiazepine usage in deliberate self harm, it was more
than the double quoted in the western data i.e. 80%.6
However the predominant method of getting these drugs
was their availability over the counter in 44% cases, the fact
which can be safely generalized to almost all developing
nations. 
In the context of Pakistan general physicians
prescribe these medications with great fervor, with out
educating the patients regarding the potential for
dependence and abuse. In a general survey of visitors
coming to Aga Khan University Hospital, a group of 7
medical students inquired about the knowledge, awareness
and practices related to benzodiazepines.7 Among 475
participants' 38% reported current use of one or the other
compound; 68.3% used them for sleep, 52.2% for stress or
anxiety, 10.9% for Ghabrahat, 7% for depression, 0.8% for
fits and 10.2% for other reasons. On inquiry 85%
participants reported that these medications were prescribed
by Physicians at some point in time. Among these
Physicians 60% were general practitioners. 
During this survey it was discovered that around
80% people were aware of one or more brand of
benzodiazepines - available over the counter. Among these
67% had some idea that if these medications are used for a
longer duration than they can become a liability. It was
noted that their potential for dependence and subsequent
abuse was a major concern. 
In another cross sectional survey, exploring the point
prevalence of benzodiazepines use at a tertiary care hospital
in Karachi, another team of seven medical students
randomly selected and interviewed 205 patients. The point
prevalence of the benzodiazepines was 21.2%. Prevalence
estimated in Psychiatry inpatients were 62%.8 Another
study exploring help seeking behaviour in psychiatric out-
patients detected a point prevalence of around 22%.9
A cross sectional of Medical students at Aga Khan
University, exploring attitude and awareness towards drug
use, showed some concerning opinions. A large majority of
them was tolerant towards self-prescription of
benzodiazepine for short term use. Though these drugs
might be helpful in short term alleviation of stress, they
nevertheless can lead to serious consequences.10
In order to understand the growing problem of
benzodiazepine use, we have to explore various market
forces, which continue to perpetuate this menace. 
Economics factors:  
According to one estimate psychotropic drug sale in
Pakistan for a duration of one year (June 2003-4) were
worth 2.76 billion; of these tranquilizers and hypnotics were
1.36 billions with a rising trend of 18% and 137%
respectively from previous year.11 Situation is not any
different in UK. Department of Health data reports that
General Practitioners in England wrote 12.7 million
prescriptions at a cost of £20.9 million in 2002, compared to
15.8 million prescriptions worth £13.8 million in 1992. 30%
of prescriptions were for 56 or more tablets. People over 65
years received 56% of prescriptions for the three most
commonly prescribed benzodiazepines.12
In the context of Pakistan Pharmaceutical
companies, driven by economic gains, marketing these
tablets as absolute recipe for peace of mind. Most
Physicians act as 'agents' for sales and promotion; with their
share in the cake. Health care in the private sector is an
industry and is driven by the 'profit motive.' Ipso facto,
hospitals are less an instrument for providing relief from
suffering than money-making machines. The position of
medical profession, by and large, is no more, to put it in
kind words, a noble profession; self-serving motives
dominate. Ultimately it is the patients and their families
who have to pay the cost - be it the lavish luncheons in five
star hotels or cruise trips to exotic location. This is
obviously done in the guise of science, technology and
promotion of 'robust' evidence
Government spends less than 1% of GDP on health
care.11 Hospitals in public sector do not exist to the needed
measure and existing ones are understaffed and
undernourished with regard to doctor-patient ratio (which
results in care-less mood of doctors), medicine and
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diagnostic tools. The masses have no option but to be let
exploited by the hospitals in private sector. As it is an issue
pertaining to masses, it is not a national issue; Islamabad,
capital of Pakistan is five miles away from Pakistan and due
to this remoteness, those who matter feel, as research in
human behavior reveals, no moral qualms in inflicting pain
on masses by not regulating and monitoring private
hospitals. 
Possible solutions: 
Any possible solutions have to keep in mind the
clinical as well as public health perspective to this problem.
In UK, it is deemed a 'good practice' as not to prescribe or
dispense the Benzodiazepines for more than 28-day.
Though GP's can prescribe the drug for a longer duration,
patients need to be cautioned regarding the potential for
addiction. Those who have developed the Dependence
syndrome need to be referred to specialists or Substance
abuse clinic. The National Institute of Clinical excellence
(NICE) guidelines offers practical directions on clinical use
of Benzodiazepines.13 In general, the three rules that apply
to benzodiazepine are that prescribing should be kept to a
minimum, reviewed regularly and discontinued as soon as
possible. 
A public health approach to the menace of
benzodiazepine dependence should focus at multiple level;
primary, secondary and tertiary prevention strategies should
be designed. Following recommendations can be helpful in
curtailing the problem of Benzodiazepine misuse: 
 Arrange Public awareness program 
 Organize regular C.M.E programs involving G.P's
 Develop Good practice guidelines for drug prescription
 Better Drug regulation and dispensing mechanisms  
 Need to develop and implement Legislation   
 Early recognition and referral to mental health services 
 Need to establish well staffed Rehabilitation centers.
Though we are at a cross-road of managing the fall
outs of Benzodiazepines use, it is important to have a re-
look at their clinical utility. Those who are using these
medications find themselves in the slow sand of Addiction.
If this situation is to change, then information needs to be
disseminated to all stakeholders.   
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